Celiac disease: advances in treatment via gluten modification.

[1]  J. Murray,et al.  The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. , 2012, Gastroenterology.

[2]  Andrew G. Spencer,et al.  Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials , 2012, Digestive Diseases and Sciences.

[3]  L. Greco,et al.  Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  D. Noto,et al.  Searching for wheat plants with low toxicity in celiac disease: Between direct toxicity and immunologic activation. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  C. Rizzello,et al.  Gluten-free Sourdough Wheat Baked Goods Appear Safe for Young Celiac Patients: A Pilot Study , 2010, Journal of pediatric gastroenterology and nutrition.

[6]  R. Ffrench,et al.  The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. , 2010, Clinical immunology.

[7]  G. M. Gray,et al.  A Food-Grade Enzyme Preparation with Modest Gluten Detoxification Properties , 2009, PloS one.

[8]  C. Schuit,et al.  Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines , 2009, BMC Plant Biology.

[9]  N. Di Fonzo,et al.  Celiac disease: in vitro and in vivo safety and palatability of wheat-free sorghum food products. , 2007, Clinical nutrition.

[10]  Paolo Bergamo,et al.  Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. , 2007, Gastroenterology.

[11]  Andrew G. Spencer,et al.  Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. , 2007, Gastroenterology.

[12]  J. Drijfhout,et al.  Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease , 2007, Gut.

[13]  A. Fasano,et al.  A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. , 2007, The American journal of clinical nutrition.

[14]  F. Koning,et al.  Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[15]  J. Drijfhout,et al.  Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. , 2005, Gastroenterology.

[16]  R. Di Cagno,et al.  Pasta made from durum wheat semolina fermented with selected lactobacilli as a tool for a potential decrease of the gluten intolerance. , 2005, Journal of agricultural and food chemistry.

[17]  M. Ráki,et al.  Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. , 2005, Gastroenterology.

[18]  L. Greco,et al.  Sourdough Bread Made from Wheat and Nontoxic Flours and Started with Selected Lactobacilli Is Tolerated in Celiac Sprue Patients , 2004, Applied and Environmental Microbiology.

[19]  G. Corazza,et al.  Wheat deficient in gliadins: promising tool for treatment of coeliac disease. , 1995, Gut.

[20]  Banes-Berceli Specialties , 1869, The Dental register.